CVS Health Corporation (CVS) Receiving Somewhat Favorable Press Coverage, Report Shows

News headlines about CVS Health Corporation (NYSE:CVS) have been trending somewhat positive on Sunday, according to Accern Sentiment Analysis. The research firm identifies negative and positive press coverage by analyzing more than twenty million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. CVS Health Corporation earned a daily sentiment score of 0.09 on Accern’s scale. Accern also assigned news articles about the pharmacy operator an impact score of 45.5580777520994 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the next few days.

These are some of the news articles that may have effected Accern Sentiment Analysis’s scoring:

CVS Health Corporation (NYSE CVS) traded up 0.09% during midday trading on Friday, hitting $79.63. The stock had a trading volume of 6,534,109 shares. CVS Health Corporation has a 12 month low of $69.30 and a 12 month high of $90.85. The stock has a 50 day moving average of $79.11 and a 200 day moving average of $78.98. The stock has a market cap of $80.95 billion, a price-to-earnings ratio of 15.86 and a beta of 0.92.

CVS Health Corporation (NYSE:CVS) last posted its quarterly earnings results on Tuesday, August 8th. The pharmacy operator reported $1.33 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.31 by $0.02. The firm had revenue of $45.69 billion during the quarter, compared to analysts’ expectations of $45.36 billion. CVS Health Corporation had a net margin of 2.93% and a return on equity of 17.47%. The firm’s revenue for the quarter was up 4.5% on a year-over-year basis. During the same period in the prior year, the company posted $1.32 earnings per share. Analysts expect that CVS Health Corporation will post $5.88 EPS for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Friday, November 3rd. Investors of record on Tuesday, October 24th will be issued a dividend of $0.50 per share. The ex-dividend date is Monday, October 23rd. This represents a $2.00 annualized dividend and a yield of 2.51%. CVS Health Corporation’s dividend payout ratio is currently 39.92%.

A number of analysts have recently weighed in on CVS shares. Jefferies Group LLC reissued a “hold” rating and issued a $82.00 price objective on shares of CVS Health Corporation in a research report on Friday, June 9th. Cowen and Company restated an “outperform” rating and issued a $86.00 target price on shares of CVS Health Corporation in a research note on Tuesday, June 13th. Royal Bank Of Canada began coverage on CVS Health Corporation in a research note on Tuesday, September 19th. They issued an “outperform” rating and a $95.00 target price for the company. ValuEngine lowered CVS Health Corporation from a “buy” rating to a “hold” rating in a research note on Friday, June 2nd. Finally, Leerink Swann set a $90.00 target price on CVS Health Corporation and gave the stock a “buy” rating in a research note on Tuesday, June 27th. One research analyst has rated the stock with a sell rating, eight have issued a hold rating and fifteen have issued a buy rating to the company’s stock. CVS Health Corporation currently has a consensus rating of “Buy” and a consensus price target of $90.58.

ILLEGAL ACTIVITY NOTICE: “CVS Health Corporation (CVS) Receiving Somewhat Favorable Press Coverage, Report Shows” was first posted by StockNewsTimes and is the property of of StockNewsTimes. If you are viewing this report on another publication, it was stolen and reposted in violation of international trademark & copyright law. The correct version of this report can be read at https://stocknewstimes.com/2017/09/25/cvs-health-corporation-cvs-receiving-somewhat-favorable-press-coverage-report-shows.html.

In related news, COO Jonathan C. Roberts sold 85,743 shares of the stock in a transaction dated Monday, September 18th. The shares were sold at an average price of $83.14, for a total transaction of $7,128,673.02. Following the completion of the transaction, the chief operating officer now directly owns 119,555 shares of the company’s stock, valued at $9,939,802.70. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Helena Foulkes sold 20,333 shares of the stock in a transaction dated Monday, June 26th. The stock was sold at an average price of $80.00, for a total transaction of $1,626,640.00. Following the transaction, the executive vice president now directly owns 59,301 shares of the company’s stock, valued at $4,744,080. The disclosure for this sale can be found here. Insiders have sold 716,411 shares of company stock valued at $58,277,271 over the last three months. 0.61% of the stock is currently owned by corporate insiders.

About CVS Health Corporation

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.

Insider Buying and Selling by Quarter for CVS Health Corporation (NYSE:CVS)

Receive News & Ratings for CVS Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply